225 tracked 13F filers disclose a position in APGE as of the latest SEC 13F filings, a combined $5.4B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management, Inc. | Withheld | 10.3M | ▲+277% Added · +7.6M sh | Q1 2026 | |
| 2 | FMR LLC | $779.6M | 9.3M | ▲+13% Added · +1.0M sh | Q1 2026 | |
| 3 | Venrock Adviser, LLC | $714.9M | 8.5M | —Held | Q1 2026 | |
| 4 | BlackRock, Inc. | $343.9M | 4.1M | ▲+8.0% Added · +302K sh | Q1 2026 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $210.6M | 2.5M | →First observed position No prior filed position | Q1 2026 | |
| 6 | JANUS HENDERSON GROUP PLC | $198.8M | 2.4M | ▲+14% Added · +298K sh | Q1 2026 | |
| 7 | STATE STREET CORP | $305.0M | 2.3M | ▲+6.2% Added · +135K sh | Q2 2026 | |
| 8 | PERCEPTIVE ADVISORS LLC | $129.7M | 1.5M | ▼−34% Reduced · −790K sh | Q1 2026 | |
| 9 | Paradigm Biocapital Advisors LP | $113.5M | 1.3M | ▲+20% Added · +225K sh | Q1 2026 | |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $174.6M | 1.3M | ▲+8.0% Added · +98K sh | Q2 2026 | |
| 11 | Affinity Asset Advisors, LLC | $108.2M | 1.3M | ▲+4.0% Added · +50K sh | Q1 2026 | |
| 12 | UBS Group AG | $96.3M | 1.1M | ▲+17% Added · +170K sh | Q1 2026 | |
| 13 | PRICE T ROWE ASSOCIATES INC /MD/ | $96.2M | 1.1M | ▼−7.6% Reduced · −94K sh | Q1 2026 | |
| 14 | JPMORGAN CHASE & CO | $87.4M | 1.1M | ▼−19% Reduced · −263K sh | Q1 2026 | |
| 15 | Vestal Point Capital, LP | $92.6M | 1.1M | ▲+100% Added · +550K sh | Q1 2026 | |
| 16 | ALLIANCEBERNSTEIN L.P. | $74.7M | 990K | ▼−9.4% Reduced · −103K sh | Q1 2026 | |
| 17 | BANK OF AMERICA CORP /DE/ | $75.8M | 901K | ▲+14% Added · +107K sh | Q1 2026 | |
| 18 | MERCER GLOBAL ADVISORS INC /ADV | $70.0M | 831K | ▼−6.7% Reduced · −59K sh | Q1 2026 | |
| 19 | Kryger Capital LLC | $98.6M | 743K | ▲New +743K sh | Q2 2026 | |
| 20 | GOLDMAN SACHS GROUP INC | $54.9M | 653K | ▲+15% Added · +87K sh | Q1 2026 | |
| 21 | CITADEL ADVISORS LLC | $50.4M | 599K | ▼−22% Reduced · −168K sh | Q1 2026 | |
| 22 | MORGAN STANLEY | $50.1M | 595K | ▼−33% Reduced · −295K sh | Q1 2026 | |
| 23 | Remedium Capital Partners, LLC | $77.9M | 587K | ▲+0.5% Added · +3K sh | Q2 2026 | |
| 24 | JENNISON ASSOCIATES LLC | $49.2M | 585K | ▲+1.1% Added · +6K sh | Q1 2026 | |
| 25 | First Light Asset Management, LLC | $48.5M | 577K | ▲+102% Added · +292K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 21 funds opened a new position in APGE and 26 added to an existing one, while 17 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| NVIDIA CORPNVDA | 116 funds | $319.6B |
| MICROSOFT CORPMSFT | 116 funds | $213.2B |
| AMAZON.COM INCAMZN | 114 funds | $161.7B |
| META PLATFORMS INC-CLASS AMETA | 111 funds | $96.8B |
| BROADCOM INCAVGO | 110 funds | $127.2B |
| ELI LILLY & COLLY | 110 funds | $64.1B |
| APPLE INCAAPL | 109 funds | $232.8B |
| NUVALENT INC-ANUVL | 109 funds | $2.1B |
| ALPHABET INC-CL AGOOGL | 108 funds | $135.0B |
| MICRON TECHNOLOGY INCMU | 108 funds | $31.3B |
| ELECTRONIC ARTS INCEA | 108 funds | $5.7B |
| BANK OF AMERICA CORPBAC | 107 funds | $23.0B |
Ranked by how many of APGE's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 5, 2026 | Dambkowski Carl | Chief Medical Officer | Sell (S) | 6K | $738K |
| Jul 8, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 20K | $2.7M |
| Jul 1, 2026 | Dambkowski Carl | Chief Medical Officer | Sell (S) | 6K | $730K |
| Jun 22, 2026 | Dambkowski Carl | Chief Medical Officer | Sell (S) | 26K | $3.5M |
| Jun 22, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 80K | $10.6M |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 7K | $557K |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 8K | $634K |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 1K | $91K |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 2K | $134K |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 2K | $199K |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 614 | $53K |
| Jun 3, 2026 | Dambkowski Carl | Chief Medical Officer | Sell (S) | 6K | $433K |
Connected entities for APGE
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/APGE/capital-change-brief"
Use Arkolith's capital_change_brief for APGE. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for APGE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.